To Acne and Beyond: A Review of Sarecycline's Off-Label Uses

September 2024 | Volume 23 | Issue 9 | Features | 792 | Copyright © September 2024

Read More

FULL SUPPLEMENT: Looking Beyond the Skin, Examining the Patient and Clinician Reported Outcomes and Effects of Acne Vulgaris and Sarecycline Treatment

February 2024 | Volume 23 | Issue 2 | Department | SF405634s1 | Copyright © February 2024

INDIVIDUAL ARTICLE: Vehicles Matter!

February 2024 | Volume 23 | Issue 2 | Supplement Individual Articles | SF378969s3 | Copyright © February 2024

Read More

INDIVIDUAL ARTICLE: Sarecycline Improves Acne Severity, Symptoms, and Psychosocial Burden in Non-nodular Acne Vulgaris: PROSES Study

February 2024 | Volume 23 | Issue 2 | Supplement Individual Articles | SF405634s12 | Copyright © February 2024

INDIVIDUAL ARTICLE: Impact of Acne Vulgaris and Sarecycline on Social/Emotional Functioning and Daily Activities: PROSES Study

February 2024 | Volume 23 | Issue 2 | Supplement Individual Articles | SF405634s5 | Copyright © February 2024

INDIVIDUAL ARTICLE: Assessing the Impact of Acne and Its Treatment on Disease Burden and Quality of Life

February 2024 | Volume 23 | Issue 2 | Supplement Individual Articles | SF405634s4 | Copyright © February 2024

Read More

Sarecycline as a Potential Treatment for Steroid-Induced Rosacea/Perioral Dermatitis: A Case Report

February 2024 | Volume 23 | Issue 2 | Case Reports | e55 | Copyright © February 2024

Read More

Ensuring Dermatologists Practice Enhanced Antibiotic Stewardship With Sarecycline Mnemonic

October 2023 | Volume 22 | Issue 10 | Editorials | 1061 | Copyright © October 2023

It must be ensured that dermatologists practice enhanced antibiotic stewardship to combat antimicrobial resistance and negative consequences of microbiome dysbiosis. In order to help achieve this, we ...
Read More

Trends in Oral Antibiotic Use for Acne Treatment: A Retrospective, Population-Based Study in the United States, 2014 to 2016

March 2023 | Volume 22 | Issue 3 | Original Article | 265 | Copyright © March 2023

Background: Antibiotic resistance related to prolonged antibiotic use is an emerging threat to public health. Objective: To evaluate recent trends in oral antibiotic use for acne trea...
Read More

SUPPLEMENT INDIVIDUAL ARTICLES: Update on Truncal Acne: A Review of Treatments for a Neglected Disease and the Re-Emergence of Tazarotene

December 2022 | Volume 21 | Issue 12 | Supplement Individual Articles | SF3446185 | Copyright © December 2022

Acne vulgaris of the trunk carries with it a major psychosocial impact and an unmet need for adequate management. Approximately 50% of patients with facial acne also exhibit involvement of the back, c...
Read More

Supplement Article: Skin Barrier Deficiency in Rosacea: An Algorithm Integrating OTC Skincare Products Into Treatment Regimens

September 2022 | Volume 21 | Issue 9 | Supplement Individual Articles | SF3595563 | Copyright © September 2022

Introduction: Rosacea is a chronic condition involving inflammation leading to a diminished skin barrier function in sebaceous gland-rich facial skin. The current algorithm represents...
Read More

A Rare Case of Empedobacter Brevis Cutaneous Infection Treated Successfully With Oral Sarecycline

February 2022 | Volume 21 | Issue 2 | Case Reports | 201 | Copyright © February 2022

Empedobacter brevis (E. brevis) is a gram-negative, nonmotile, aerobic bacteria that is part of the Flavobacteriaceae family. It is mostly found in water sources, plants, soils, and more recently, hos...
Read More

Fifty Years of Minocycline and Its Evolution: A Dermatological Perspective

October 2021 | Volume 20 | Issue 10 | Original Article | 1031 | Copyright © October 2021

2021 is the 50th anniversary of the FDA approval of minocycline (MCN). While many other antibiotics have become obsolete during this time, MCN continues to be quite useful. In dermatology, MCN is used...
Read More

Acne Vulgaris: The Majority of Patients Do Not Achieve Success According to FDA Guidance

June 2021 | Volume 20 | Issue 6 | Original Article | 648 | Copyright © June 2021

Background: The Food and Drug Administration (FDA) recommends grading Acne vulgaris via an Investigator’s Global Assessment (IGA) scale and assessing treatment as either success...
Read More

Management of Truncal Acne With Oral Sarecycline: Pooled Results from Two Phase-3 Clinical Trials

June 2021 | Volume 20 | Issue 6 | Original Article | 634 | Copyright © June 2021

Background: Acne vulgaris is a common skin disease that affects the face, chest, and back. While truncal acne is present in at least 50% of patients, clinical studies have focused pre...
Read More

Oral Sarecycline for Treatment of Papulopustular Rosacea: Results of a Pilot Study of Effectiveness and Safety

April 2021 | Volume 20 | Issue 4 | Original Article | 426 | Copyright © April 2021

Background: Cutaneous rosacea is a common inflammatory skin disorder that often presents with facial papulopustular lesions that are frequently bothersome to patients. Studies have sh...
Read More

Successful Treatment of Periorificial Dermatitis With Novel Narrow Spectrum Sarecycline

January 2021 | Volume 20 | Issue 1 | Case Reports | 98 | Copyright © January 2021

Broad spectrum tetracyclines are a well-known, widely used, and often successful treatment for use in inflammatory skin pathologies such as acne and rosacea. However, the steady rise of antibiotic res...
Read More

ARTICLE: Oral Tetracyclines and Acne: A Systematic Review for Dermatologists

November 2020 | Volume 19 | Issue 11 | Supplement Individual Articles | s6 | Copyright © November 2020

Oral tetracyclines are the most widely prescribed systemic antibiotic for acne. Synthesis of efficacy and safety of traditional and novel oral tetracyclines is highly informative to clinical practice....
Read More

ARTICLE: A Novel Antibiotic Just for Acne

November 2020 | Volume 19 | Issue 11 | Supplement Individual Articles | s5 | Copyright © November 2020

Dermatologists consistently rank as the most frequent prescribers of systemic antibiotics, and one of the most common diagnoses for which we recommend these agents is acne vulgaris. Up to three quarte...
Read More

Consensus on Neonatal Through Preadolescent Acne

June 2020 | Volume 19 | Issue 6 | Original Article | 592 | Copyright © June 2020

Background: Acne vulgaris is the most common dermatological disorder. Pediatric acne may be a manifestation of the underlying pathology and can occur in the first weeks, months, or ye...
Read More